{"id":"NCT01956110","sponsor":"Ferring Pharmaceuticals","briefTitle":"Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1","officialTitle":"A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2015-05","completion":"2017-01-03","firstPosted":"2013-10-08","resultsPosted":"2018-09-25","lastUpdate":"2022-01-13"},"enrollment":1329,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Infertility"],"interventions":[{"type":"DRUG","name":"Follitropin Delta (FE 999049)","otherNames":[]},{"type":"DRUG","name":"Follitropin Alfa (GONAL-F)","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"ACTIVE_COMPARATOR"}],"summary":"This trial investigates the effects of FE 999049 compared to GONAL-F.","primaryOutcome":{"measure":"Ongoing Pregnancy Rate","timeFrame":"10-11 weeks after blastocyst transfer","effectByArm":[{"arm":"FE 999049","deltaMin":30.7,"sd":null},{"arm":"GONAL-F","deltaMin":31.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":7},"locations":{"siteCount":13,"countries":["Belgium","Brazil","Canada","Czechia","Denmark","France","Italy","Poland","Russia","Spain","United Kingdom"]},"refs":{"pmids":["32819842","34254211","34799275","30801744","27912901"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":665},"commonTop":["Headache","Procedural pain","Pelvic pain","Pelvic discomfort"]}}